A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion James Del RossoHilary BaldwinJonathan Weiss Commentary Open access 09 January 2024 Pages: 271 - 284
Real-World Adverse Events Associated with Encapsulated Benzoyl Peroxide/Tretinoin, 3%/0.1%, and Encapsulated Benzoyl Peroxide, 5% Amy PoteateOfra Levy-HachamJ. P. York Commentary Open access 19 January 2024 Pages: 285 - 292
Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases Lakshi M. AldredgeWinston D. ChamberlainVivian Y. Shi Commentary Open access 03 February 2024 Pages: 293 - 302
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies Hannah KaiserCharlotte Näslund-KochLone Skov Review Open access 30 January 2024 Pages: 303 - 321
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel Joshua BurshteinMilaan ShahMark Lebwohl Review Open access 10 February 2024 Pages: 323 - 339
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence Tina BhutaniAaron S. Farberg Review Open access 16 February 2024 Pages: 341 - 360
Applications of Ultraviolet and Sub-ultraviolet Dermatoscopy in Neoplastic and Non-neoplastic Dermatoses: A Systematic Review Paweł PietkiewiczCristian Navarrete-DechentEnzo Errichetti Review Open access 15 February 2024 Pages: 361 - 390
Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis Paul V. AndrewAbigail PinnockSimon G. Danby Original Research Open access 04 January 2024 Pages: 391 - 408
An Atlas of the Hidradenitis Suppurativa Transcriptome Weronika SzukalaAgata Lichawska-CieslarJacek C. Szepietowski Original Research Open access 06 January 2024 Pages: 409 - 420
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey April W. ArmstrongSayeli JayadeLauren Seigel Original Research Open access 22 January 2024 Pages: 421 - 439
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor) Melinda GooderhamRonald VenderLawrence Green Original Research Open access 09 February 2024 Pages: 441 - 451
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA) Kristian ReichLuca BianchiLluis Puig Original Research Open access 01 February 2024 Pages: 453 - 468
Efficacy and Safety of an Autologous Micrografting Procedure for Management of Striae Distensae in Women Leonor GirãoPedro Pinto Original Research Open access 06 February 2024 Pages: 469 - 488
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Valerie J. LudbrookDavid C. BuddWei Jing Loo Original Research Open access 19 February 2024 Pages: 489 - 504
Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care Gastón RoustánMarta LoroOlga Isidoro Original Research Open access 09 February 2024 Pages: 505 - 519
Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis Andreas PinterAthanasios Tsianakasfor the ScaTAC study group Original Research Open access 12 February 2024 Pages: 521 - 532
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis Hidehisa SaekiYoko KataokaKazuhiko Arima Brief Report Open access 07 February 2024 Pages: 533 - 543
Successful Treatment of Schwartz-Jampel Syndrome with Botulinum Toxin Type A Panittra SuphatsathienkulKullasate SakpichaisakulRungsima Wanitphakdeedecha Case Report Open access 28 January 2024 Pages: 545 - 556
Correction to: Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions Dimitra KoumakiStamatios GregoriouKonstantinos Krasagakis Correction Open access 09 January 2024 Pages: 557 - 558
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study Stephen SchleicherAngela MooreBrigitte Dreno Correction Open access 12 January 2024 Pages: 559 - 561